May 2026
1. PELES I, Novack L, Gordon M, Sarov B, et al
   Acute Environmental Triggers and Intermediate-Term Modulators of Emergency Migraine-Related Health Care Encounters.
   Neurology. 2026;106:e214936.
   

   >> Share

   
   April 2026
2. JENSEN RH, Lundqvist C, Schytz HW, Tassorelli C, et al
   Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.
   Neurology. 2026;106:e214863.
   

   >> Share

   
   March 2026
3. MESSINA R, Christensen RH, Ashina H, Sankar A, et al
   Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study.
   Neurology. 2026;106:e214656.
   

   >> Share

   
   February 2026
4. CARONNA E, Mas-de-Les-Valls R, Egeo G, Millan Vazquez M, et al
   Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
   Neurology. 2026;106:e214659.
   

   >> Share

   
   
5. LUSK JB, Wilson LE, Moore C, Yarnell S, et al
   Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
   Neurology. 2026;106:e214479.
   

   >> Share

   
   November 2025
6. PENG KP, Mehnert J, May A
   Neuronal Dynamics of Menstrually Related Migraine: A Longitudinal Task-Based fMRI Study.
   Neurology. 2025;105:e214234.
   

   >> Share

   
   
7. COOK JT, Prasad S, Ozudogru S, Ellis CA, et al
   Pearls & Oy-sters: Attacks of Hemiplegic Migraine and Encephalopathy in SLC4A4 Pathogenic Variants.
   Neurology. 2025;105:e214231.
   

   >> Share

   
   
8. TU YH, Huang TC, Tzeng YS, Chen SP, et al
   Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
   Neurology. 2025;105:e214248.
   

   >> Share

   
   
9. JANG SI, Kim N, Han K, Lee MJ, et al
   Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
   Neurology. 2025;105:e214252.
   

   >> Share

   
   September 2025
10. XUAN Z, Pan Z, Ma C, Lin X, et al
    Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210094.
    

    >> Share

    
    
11. SCHULZ RS, Rist PM, Kurth T
    Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210158.
    

    >> Share

    
    
12. GANESH A, Galetta SL
    Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e214084.
    

    >> Share

    
    July 2025
13. ELLER MT, Schwarzova K, Gufler L, Karisik A, et al
    CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review.
    Neurology. 2025;105:e213852.
    

    >> Share

    
    June 2025
14. CAMANNI M, van Gelder MMHJ, Cantarutti A, Nordeng H, et al
    Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring.
    Neurology. 2025;104:e213678.
    

    >> Share

    
    March 2025
15. KELLIER D, Anto MM, Hall M, Marin J, et al
    Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache.
    Neurology. 2025;104:e213351.
    

    >> Share

    
    
16. SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al
    Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
    Neurology. 2025;104:e210235.
    

    >> Share

    
    February 2025
17. HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al
    Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.
    Neurology. 2025;104:e210220.
    

    >> Share

    
    January 2025
18. LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al
    Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.
    Neurology. 2025;104:e210212.
    

    >> Share

    
    
19. LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al
    Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
    Neurology. 2025;104:e210203.
    

    >> Share

    
    December 2024
20. BONNESEN K, Fuglsang CH, Schmidt M
    Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
    Neurology. 2024;103:e210034.
    

    >> Share

    
    
21. WANG K, Sico JJ
    Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer Choice?
    Neurology. 2024;103:e210196.
    

    >> Share

    
    November 2024
22. 
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209868.
    

    >> Share

    
    
23. ALLEN C, Rastall DP
    Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
    Neurology. 2024;103:e209957.
    

    >> Share

    
    
24. 
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e210022.
    

    >> Share

    
    September 2024
25. KUMAR A, Joshi D, Singh VK
    Harlequin Syndrome: A Rare Association With Migraine.
    Neurology. 2024;103:e209792.
    

    >> Share

    
    
26. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
    Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2024;103:e209747.
    

    >> Share

    
    
27. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
    Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
    Neurology. 2024;103:e209745.
    

    >> Share

    
    August 2024
28. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e209700.
    

    >> Share

    
    July 2024
29. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209584.
    

    >> Share

    
    May 2024
30. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
    Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
    Neurology. 2024;102:e209305.
    

    >> Share

    
    
31. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
    Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
    Neurology. 2024;102:e209349.
    

    >> Share

    
    April 2024
32. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
    Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
    Neurology. 2024;102:e209248.
    

    >> Share

    
    
33. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
    Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
    Neurology. 2024;102:e209224.
    

    >> Share

    
    
34. PETROVA M, Besedina O, Hare B, Gupta A, et al
    Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005).
    Neurology. 2024;102.
    

    >> Share

    
    
35. BLUMENFELD A, Mechtler L, Cook L, Rhyne C, et al
    Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001).
    Neurology. 2024;102.
    

    >> Share

    
    February 2024
36. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    

    >> Share

    
    
37. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    

    >> Share

    
    
38. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    

    >> Share

    
    
39. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    

    >> Share

    
    January 2024
40. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    

    >> Share

    
    November 2023
41. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    

    >> Share

    
    
42. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    

    >> Share

    
    August 2023
43. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    

    >> Share

    
    
44. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    

    >> Share

    
    July 2023
45. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    

    >> Share

    
    
46. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    

    >> Share

    
    
47. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    

    >> Share

    
    June 2023
48. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    

    >> Share

    
    May 2023
49. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    

    >> Share

    
    
50. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    

    >> Share

    
    
51. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    

    >> Share

    
    April 2023
52. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    

    >> Share

    
    
53. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    

    >> Share

    
    
54. 
    Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    

    >> Share

    
    March 2023
55. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    

    >> Share

    
    
56. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    

    >> Share

    
    August 2022
57. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share